EMPA-KIDNEY study

Document ID: SC-VN-02613

123,000
Views

100k 340

Related Articles

EMPA-KIDNEY study results infographic

EMPA-KIDNEY full study publication

EMPA-KIDNEY baseline infographic

EMPA-KIDNEY baseline publication

This medical educational webinar is intended for healthcare professionals only to communicate clinical trial updates in the EMPOWER program, including the EMPA-KIDNEY trial. Empagliflozin is currently not indicated for the treatment of chronic kidney disease. Please refer to the local product information for the current indication in your country.
SC-VN-02613